Houston Methodist Department of Ophthalmology — Blanton Eye Institute

The Houston Methodist Blanton Eye Institute is a nationally acclaimed team specializing in the medical and surgical treatment of eye disorders and diseases. In the clinical setting, Houston Methodist takes on the most challenging and groundbreaking ophthalmic cases, procedures and research initiatives.

 

As one of the few medical centers nationwide to offer dedicated ocular pathology — which allows physicians to immediately assess malignancy in eye tumors and determine appropriate treatment — Houston Methodist is an innovation leader in ocular oncology. Our clinicians and faculty also collaborate with some of the world’s top specialists in neurology, neurosurgery, neuro-oncology and metabolic diseases.

Our Team

The highly respected team of faculty and clinicians strives to treat “the sickest eyes in the sickest patients.” This means they routinely assume care for difficult and challenging hospital patients with significant and potentially life-threatening systemic disease, such as organ transplants, chronic immunosuppression and metastatic cancer.

 

The Blanton Eye Institute’s open staff model allows the center to unite patients with the expertise of multiple providers across multiple specialties. It also creates advantageous partnership opportunities in clinical care, education and research. 


Our Faculty ➝  Our Physicians ➝ 

 

3

Active Clinical Trials

22

Academic Partners

2

GME Trainees

166

Peer-Reviewed Publications

Our Research

The Blanton Eye Institute team partners with clinical and faculty colleagues at Houston Methodist in neuroimaging, radiation therapy and oncology are leading the way in novel and exciting treatments for intraocular cancer. 

 

The team has also partnered with Retina Consultants of Texas (RCTX) to participate in several national clinical trials. One unique trial explores the treatment of non-arteritic anterior ischemic optic neuropathy using intravitreal injections of a novel, silencing RNA molecule.

 

Additionally, in partnership with NASA, members of the Blanton Eye Institute engage in research around Spaceflight Associated Neuro-ocular Syndrome (SANS)—the effects of long-duration space flight on the eye. This has been an area of clinical and research interest for many members of the Blanton Eye Institute.

 

Departmental vice chair for research, David Brown, MD, from RCTX, and department chair, Andrew G. Lee, serve key members of NASA’s research advisory panel for SANS, which works to prevent the effects of long-term space travel in preparation for future manned missions, including missions to Mars.

Improved Options for RVD
In Phase III clinical trials, Faricimab met noninferiority endpoints over aflibercept to treat diabetic macular edema and neovascular macular degeneration.
Keeping an Eye on COVID-19
A Houston Methodist team conducted an extensive study assessing the impact of COVID-19 on neuro-ophthalmology practices in the United States.
Diabetic Retinopathy Study
Study finds the presence of predominantly peripheral lesions on ultra-widefield fluorescein angiography may require follow-up care.
Spaceflight Associated Neuro-Ocular Syndrome
Dr. Andrew Lee contributed to this paper exploring the proposed pathogenesis, terrestrial analogues and emerging countermeasures for SANS.

Education & Training

The Department of Ophthalmology — in collaboration with its 22 academic partners with joint appointments from institutions such as Texas A&M College of Medicine, Weill Cornell Medicine, The University of Texas Medical Branch at Galveston and others — builds upon a strong foundation in research and education.

 

Faculty academic credentials include society and clinical trial leadership, national podium presentations and lecture invitations from around the globe. Their faculty also dedicate time to the hands-on training of fellows, and they coordinate hundreds of educational opportunities each year, including conferences, seminars, weekly Grand Rounds and more.

 
Neuro-Ophthalmology Fellowship
Houston Methodist and University of Texas MD Anderson Cancer Center train ophthalmology researchers interested in neuro-ophthalmology careers.
Ophthalmic Pathology Fellowship
Program for physicians with pathology specialty training interested in a career in ophthalmic pathology or ophthalmology and related research.
Medical Retina Fellowship
Training in medical and surgical retina subspecialties including uveitis, ocular oncology, hereditary retinal diseases, clinical research, exposure to neuro-ophthalmology.
Geriatric Ophthalmology Symposium
June 15, 2024: Annual Symposium on Enhancing Geriatric Understanding and Education (SEGUE): Polypharmacy and Elder Abuse in Geriatric Ophthalmology. 
For Patients

For Patients

Houston Methodist’s ophthalmology experts use cutting-edge diagnostic technologies and surgeries to prevent, diagnose, manage and treat the full range of eye and vision diseases, including conditions and surgeries such as macular degeneration, ocular melanoma, corneal transplant, glaucoma, thyroid eye disease, diabetic retinopathy and more.

Department of Ophthalmology News & Events

Leading Medicine Blog — For Professionals
In The News — Recent Press
Events — Virtual & In-Person
Leading Medicine Blog — For Professionals
In The News — Recent Press
Events — Virtual & In-Person